Qiagen issues outlook for 2020 and 2021

 

• Qiagen (NYSE:QGEN) provides FY 2020 outlook for growth of net sales and adjusted EPS and is looking forward to another strong performance in 2021.
• The company expects net sales for Q4 to grow at least 32% at CER, and for adjusted EPS to increase to ~$0.64-0.65 CER.
• FY 2020 net sales now expected to grow ~22% CER and adjusted EPS to reach $2.13-2.14 CER.
• Outlook for full-year 2021 raised to 18-20% CER net sales growth and adjusted EPS of $2.42-2.46 CER
• Additionally, Qiagen announced that its Supervisory Board plans to expand the number of members from the current level of six to complement and enhance the Board’s already extensive expertise and experience in Life Sciences and diagnostics.
• The company plans to hold a Virtual Deep Dive today, from 10:30-13:00 EST to provide a strategic and financial update.
• https://seekingalpha.com/news/3642371-qiagen-issues-outlook-for-2020-and-2021